Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

<i>Introduction</i>: Several immune checkpoint inhibitors (CPIs) are under clinical development in hepatocellular carcinoma (HCC) and the field is advancing rapidly. In this comprehensive review, we discuss published results and report on ongoing clinical trials. <i>Methods</i&g...

Full description

Bibliographic Details
Main Authors: Anne Dyhl-Polk, Marta Kramer Mikkelsen, Morten Ladekarl, Dorte Lisbet Nielsen
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
checkpoint inhibitor
immunotherapy
hepatocellular carcinoma
review
Online Access:https://www.mdpi.com/2077-0383/10/12/2662

Internet

https://www.mdpi.com/2077-0383/10/12/2662

Similar Items